KOPRAN
|
The Current P/S Ratio of KOPRAN is 0.95.
| Share Price | ₹122.3 | Mar 12,2026 |
| Market Cap | ₹590.5 Cr | |
| Sales-TTM | ₹619.8 Cr | TTM-Consolidated Results |
| Price/Sales | 0.95x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of KOPRAN
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹590.5 Cr] as on Mar 12,2026
(/) Sales [ ₹619.8 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 0.95x ]
Thus, for KOPRAN , the investors are currently willing to pay '0.95 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of KOPRAN !
The chart below summarizes the trend in P/S Ratio of KOPRAN over the last five years.
Historical PS (Price/Sales) ratio chart of KOPRAN
PS Ratio Performance Analysis for KOPRAN
- KOPRAN 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.62x.
- KOPRAN 's operated at median p/e ratio of 1.34x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KOPRAN 's p/e ratio peaked in Mar2022 at 2.84x.
- KOPRAN 's p/e ratio hit its five-year low in Mar2021 of 0.92x.
How does KOPRAN 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| KOPRAN | 619.8 | 0.95 | 590.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.71 | 437,879.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.15 | 166,620.0 |
| CIPLA LTD | 28,351.1 | 3.78 | 107,051.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.81 | 150,431.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.17 | 110,070.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.55 | 91,161.8 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.54 | 92,226.4 |
| LUPIN LTD | 26,150.5 | 4.12 | 107,718.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.30 | 76,276.7 |
| ABBOTT INDIA LTD | 6,824.1 | 8.31 | 56,725.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs KOPRAN 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 0.95x |
| Max industry PS | 16.15x |
| Median industry PS | 4.12x |
| Average industry PS | 6.22x |
You may also like the below Video Courses